wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33439312-67D5B2C9-B1A3-4A52-8FF1-A6A91B168213
Q33439312-67D5B2C9-B1A3-4A52-8FF1-A6A91B168213
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33439312-67D5B2C9-B1A3-4A52-8FF1-A6A91B168213
Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors.
P2093
Q33439312-67D5B2C9-B1A3-4A52-8FF1-A6A91B168213
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33439312-67D5B2C9-B1A3-4A52-8FF1-A6A91B168213
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
56545dd5fffad85838e86897d750d1cd24922b22
P1545
7
http://www.w3.org/2001/XMLSchema#string
P2093
Wei Guo
http://www.w3.org/2001/XMLSchema#string